ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0960

The Risk of Venous Thromboembolism After Septic Total Knee Replacement (TKR) Revision Is Double the Risk After Aseptic TKR Revision: An Analysis of Administrative Discharge Data

Anne Bass1, Bella Mehta1, Peter Sculco1, Yi Zhang2, Huong Do2, Linda Russell1 and Susan Goodman3, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: ACR Convergence 2020

Keywords: Arthritis, Infectious, Epidemiology, Osteoarthritis, Prosthetic Joint, Total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Orthopedics, Low Back Pain, & Rehabilitation (0960–0964)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Infection can trigger coagulation pathways and increase the risk of thrombosis. However, the impact of infection on postoperative venous thromboembolism (VTE) risk is poorly defined. The aim of this study was to assess the 90-day risk of VTE following total knee replacement (TKR) revision by indication for revision to estimate the impact of infection on postoperative VTE risk.

Methods: We used New York Statewide Planning and Research Cooperative System data to identify all New York State residents undergoing TKR revision from 1998 to 2014. Only the first revision was included for patients undergoing multiple revisions. ICD-9-CM codes were used to identify patient comorbidities and classify indication for TKR revision as aseptic, septic or fracture. The primary outcome was any diagnosis code for VTE (pulmonary embolism and/or deep vein thrombosis) recorded for the revision surgery and/or subsequent admissions within 90 days. A multivariable logistic regression analysis adjusting for demographics and comorbidities was performed to estimate the risk of VTE after septic vs aseptic revision TKR, and of fracture-related revision vs. aseptic revision.

Results: This study included 25,441 TKR revision surgeries, 17,563 (69%) of them aseptic, 7075 (28%) septic and 803 (3%) for fracture. Mean (SD) age was 66 (12) years, 15,592 (61%) were female, 3198 (12%) were black, 1192 (5%) were smokers and 4222 (17%) were obese (Table 1). A total of 719 (2.8%) patients experienced VTE within 90 days of revision TKR, 387 (1.5%) during the index admission. The 90-day incidence of VTE was 2.1% after aseptic revision,  4.3% after septic revision and  5.9% after revision for fracture (Table 2). The 90-day incidence of pulmonary embolism was 0.7% after aseptic revision, 1.0% after septic revision and 1.9% after revision for fracture. The adjusted odds ratio (OR) for VTE relative to aseptic revision was 2.01 (95% CI 1.72-2.36) for septic TKR revision and 2.61 (95% CI 1.9-3.58) for fracture-related TKR revision (Table 3). Prior history of VTE was also a risk factor for post revision VTE (OR 2.01, 95% CI 1.48-2.71, p< 0.001).

Conclusion: The risk of VTE after septic TKR revision is double that after aseptic TKR revision.  Although fractures account for a small percentage of TKR revisions, the risk of VTE is 2.6-fold higher after those procedures. VTE prophylaxis guidelines should distinguish between the indications for TKR revision, and potent/fast acting VTE prophylaxis should be strongly considered in those with infection or fracture.

Table 1: Cohort description of Total Knee Replacement revisions

Table 2: VTE within 90 days of aseptic, septic and fracture-related TKR revision

Table 3: Risk of VTE within 90 days of septic and fracture TKR revision in comparison to aseptic TKR revision: results of multivariable logistic regression analysis


Disclosure: A. Bass, None; B. Mehta, None; P. Sculco, EOS imaging, 1, Intellijoint Surgical, 1, Depuy Synthes, 1, Lima Corporate, 1; Y. Zhang, None; H. Do, None; L. Russell, None; S. Goodman, Pfizer, 1, Novartis, 1, UCB, 1, regenosine, 1, 2, Horizon, 1.

To cite this abstract in AMA style:

Bass A, Mehta B, Sculco P, Zhang Y, Do H, Russell L, Goodman S. The Risk of Venous Thromboembolism After Septic Total Knee Replacement (TKR) Revision Is Double the Risk After Aseptic TKR Revision: An Analysis of Administrative Discharge Data [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-risk-of-venous-thromboembolism-after-septic-total-knee-replacement-tkr-revision-is-double-the-risk-after-aseptic-tkr-revision-an-analysis-of-administrative-discharge-data/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-risk-of-venous-thromboembolism-after-septic-total-knee-replacement-tkr-revision-is-double-the-risk-after-aseptic-tkr-revision-an-analysis-of-administrative-discharge-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology